Shanghai Guotou Xian Dao and Enhua Pharmaceutical, among others, have established a venture capital fund in Shanghai.

According to the Qichacha APP, recently, the Shanghai Defu Venture Capital Partnership was established with a funding amount of approximately 217 million yuan. Its business scope includes venture capital. Qichacha's equity penetration shows that this partnership is jointly held by Shanghai Guotou Xian Dao Biomedical Private Equity Investment Partnership, Enhua Pharmaceutical, and Baile Tianheng Biomedical Technology Co., Ltd., among others.